Treatment of Upper Respiratory Tract Infections

Initial Management Approach

The European Respiratory Society recommends that common upper respiratory tract infections (URTI) are predominantly viral and should be managed with symptomatic treatment only, as antibiotics are not indicated and do not prevent progression to lower respiratory tract infections 1
Symptomatic treatment, including analgesics/antipyretics such as acetaminophen or ibuprofen for pain, fever, and inflammation, is recommended for URTI management 2
Adequate hydration and rest are recommended as supportive measures for recovery from URTI 2
Nasal saline irrigation may be considered for persistent nasal congestion, which may provide minor symptom improvement 2
For bothersome dry cough, dextromethorphan or codeine may be prescribed 2

Antibiotics should not be prescribed for uncomplicated viral URTIs, as they are ineffective against viral illness and will not prevent lower respiratory tract infections 1, 2
Mucolytics, expectorants, or bronchodilators should be avoided, as they have not shown benefit in uncomplicated viral URTIs 2

For acute bacterial rhinosinusitis, first-line treatment includes amoxicillin-clavulanate, second-generation oral cephalosporins, or third-generation oral cephalosporins 3
For beta-lactam allergies, pristinamycin or macrolides may be prescribed 3
Treatment duration for acute bacterial rhinosinusitis is 7-10 days 3
For streptococcal pharyngitis, treatment duration is 10 days 3
For acute otitis media, first-line treatment includes amoxicillin (80-100 mg/kg/day in three daily doses for children <30 kg) 4

Amoxicillin may be considered if high fever (>38.5°C) persists beyond 3 days with bothersome cough 2
Amoxicillin-clavulanate, cefuroxime-axetil, or cefpodoxime-proxetil may be used for suspected resistant organisms 3, 4

Patients should be advised to return if symptoms persist beyond 3 weeks, fever exceeds 4 days, dyspnea worsens, or the patient's condition deteriorates 2
Chest imaging may be considered if symptoms persist or worsen to rule out parenchymal lung disease 2
High-risk patients, including those with age ≥65 years, chronic cardiac or pulmonary diseases, diabetes mellitus, or chronic renal diseases, require closer monitoring 2

Antibiotics should not be prescribed empirically for viral URTIs, as this contributes to antibiotic resistance without clinical benefit 1
Antibiotics should not be used to "prevent" lower respiratory tract infections, as this approach has been proven ineffective 1
Most URTIs are self-limiting and will resolve within 1-3 weeks without specific intervention 2, 5